{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:58:20Z","timestamp":1784347100893,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00392-021-01847-6","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T22:02:32Z","timestamp":1616796152000},"page":"175-185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Alcohol-induced right bundle branch block is associated with a benign outcome in HOCM after alcohol septum ablation (ASA)"],"prefix":"10.1007","volume":"111","author":[{"given":"Dennis","family":"Lawin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Lawrenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Radke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8429-2826","authenticated-orcid":false,"given":"Christoph","family":"Stellbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"key":"1847_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1161\/01.cir.92.4.785","volume":"92","author":"BJ Maron","year":"1995","unstructured":"Maron BJ, Gardin JM, Flack JM et al (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. coronary artery risk development in (young) adults. Circulation 92:785\u2013789. https:\/\/doi.org\/10.1161\/01.cir.92.4.785","journal-title":"Circulation"},{"issue":"Suppl.F","key":"1847_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/eurheartj\/4.suppl_f.93","volume":"4","author":"H Kuhn","year":"1983","unstructured":"Kuhn H, Mercier J, K\u00f6hler E et al (1983) Differential diagnosis of hypertrophic cardiomyopathies: typical (subaortic) hypertrophic obstructive cardiomyopathy, atypical (mid-ventricular) hypertrophic obstructive cardiomyopathy and hypertrophic non-obstructive cardiomyopathy. Eur Heart J 4(Suppl.F):93\u2013104. https:\/\/doi.org\/10.1093\/eurheartj\/4.suppl_f.93","journal-title":"Eur Heart J"},{"key":"1847_CR3","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","volume":"35","author":"TF Authorsmembers, Elliott PM, Anastas","year":"2014","unstructured":"Authorsmembers, Elliott PM, Anastasakis A, TF et al (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC). Eur Heart J 35:2733\u20132779. https:\/\/doi.org\/10.1093\/eurheartj\/ehu284","journal-title":"Eur Heart J"},{"key":"1847_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1161\/01.cir.52.1.88","volume":"52","author":"AG Morrow","year":"1975","unstructured":"Morrow AG, Reitz BA, Epstein SE et al (1975) Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation 52:88\u2013102. https:\/\/doi.org\/10.1161\/01.cir.52.1.88","journal-title":"Circulation"},{"key":"1847_CR5","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/oxfordjournals.eurheartj.a015350","volume":"18","author":"H Kuhn","year":"1997","unstructured":"Kuhn H, Gietzen F, Leuner C, Gerenkamp T (1997) Induction of subaortic septal ischaemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Studies to develop a new catheter-based concept of treatment. Eur Heart J 18:846\u2013851","journal-title":"Eur Heart J"},{"key":"1847_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/s0140-6736(95)91267-3","volume":"346","author":"U Sigwart","year":"1995","unstructured":"Sigwart U (1995) Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346:211\u2013214. https:\/\/doi.org\/10.1016\/s0140-6736(95)91267-3","journal-title":"Lancet"},{"key":"1847_CR7","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jacc.2009.09.047","volume":"55","author":"S Agarwal","year":"2010","unstructured":"Agarwal S, Tuzcu EM, Desai MY et al (2010) Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy. J Am Coll Cardiol 55:823\u2013834. https:\/\/doi.org\/10.1016\/j.jacc.2009.09.047","journal-title":"J Am Coll Cardiol"},{"key":"1847_CR8","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1093\/eurheartj\/ehp016","volume":"30","author":"M Alam","year":"2009","unstructured":"Alam M, Dokainish H, Lakkis NM (2009) Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis. Eur Heart J 30:1080\u20131087. https:\/\/doi.org\/10.1093\/eurheartj\/ehp016","journal-title":"Eur Heart J"},{"key":"1847_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1161\/CIRCINTERVENTIONS.109.916676","volume":"3","author":"RA Leonardi","year":"2010","unstructured":"Leonardi RA, Kransdorf EP, Simel DL, Wang A (2010) Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment. Circ Cardiovasc Interv 3:97\u2013104. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.109.916676","journal-title":"Circ Cardiovasc Interv"},{"key":"1847_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1540-8183.2007.00220.x","volume":"20","author":"SS El-Jack","year":"2007","unstructured":"El-Jack SS, Nasif M, Blake JW et al (2007) Predictors of Complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy and the timing of pacemaker implantation. J Interv Cardiol 20:73\u201376. https:\/\/doi.org\/10.1111\/j.1540-8183.2007.00220.x","journal-title":"J Interv Cardiol"},{"key":"1847_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijcard.2006.07.179","volume":"119","author":"L Faber","year":"2007","unstructured":"Faber L, Welge D, Fassbender D et al (2007) Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: managing the risk of procedure-related AV conduction disturbances. Int J Cardiol 119:163\u2013167. https:\/\/doi.org\/10.1016\/j.ijcard.2006.07.179","journal-title":"Int J Cardiol"},{"key":"1847_CR12","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/j.jacc.2007.02.056","volume":"49","author":"T Lawrenz","year":"2007","unstructured":"Lawrenz T, Lieder F, Bartelsmeier M et al (2007) Predictors of complete heart block after transcoronary ablation of septal hypertrophy. J Am Coll Cardiol 49:2356\u20132363. https:\/\/doi.org\/10.1016\/j.jacc.2007.02.056","journal-title":"J Am Coll Cardiol"},{"key":"1847_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/ehjqcco\/qcy049","volume":"5","author":"MK Jensen","year":"2019","unstructured":"Jensen MK, Faber L, Liebregts M et al (2019) Effect of impaired cardiac conduction after alcohol septal ablation on clinical outcomes: insights from the Euro-ASA registry. Eur Heart J Qual Care Clin Outcomes 5:252\u2013258. https:\/\/doi.org\/10.1093\/ehjqcco\/qcy049","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"1847_CR14","doi-asserted-by":"publisher","first-page":"432","DOI":"10.5935\/abc.20190060","volume":"112","author":"C-Y Li","year":"2019","unstructured":"Li C-Y, Shi Y-Q (2019) Retrospective analysis of risk factors for related complications of chemical ablation on hypertrophic obstructive cardiomyopathy. Arq Bras Cardiol 112:432\u2013438. https:\/\/doi.org\/10.5935\/abc.20190060","journal-title":"Arq Bras Cardiol"},{"key":"1847_CR15","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/bjsports-2016-097331","volume":"51","author":"JA Drezner","year":"2017","unstructured":"Drezner JA, Sharma S, Baggish A et al (2017) International criteria for electrocardiographic interpretation in athletes: consensus statement. Br J Sports Med 51:704\u2013731. https:\/\/doi.org\/10.1136\/bjsports-2016-097331","journal-title":"Br J Sports Med"},{"key":"1847_CR16","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1016\/j.jacc.2011.06.073","volume":"58","author":"SF Nagueh","year":"2011","unstructured":"Nagueh SF, Groves BM, Schwartz L et al (2011) Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American Registry. J Am Coll Cardiol 58:2322\u20132328. https:\/\/doi.org\/10.1016\/j.jacc.2011.06.073","journal-title":"J Am Coll Cardiol"},{"key":"1847_CR17","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1053\/euhj.1999.1520","volume":"20","author":"FH Gietzen","year":"1999","unstructured":"Gietzen FH, Leuner CJ, Raute-Kreinsen U et al (1999) Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy. Eur Heart J 20:1342\u20131354. https:\/\/doi.org\/10.1053\/euhj.1999.1520","journal-title":"Eur Heart J"},{"key":"1847_CR18","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s00392-007-0578-9","volume":"96","author":"L Faber","year":"2007","unstructured":"Faber L, Welge D, Fassbender D et al (2007) One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response. Clin Res Cardiol 96:864\u2013873. https:\/\/doi.org\/10.1007\/s00392-007-0578-9","journal-title":"Clin Res Cardiol"},{"key":"1847_CR19","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s00392-007-0616-7","volume":"97","author":"H Kuhn","year":"2008","unstructured":"Kuhn H, Lawrenz T, Lieder F et al (2008) Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10\u00a0year experience. Clin Res Cardiol 97:234\u2013243. https:\/\/doi.org\/10.1007\/s00392-007-0616-7","journal-title":"Clin Res Cardiol"},{"key":"1847_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/01.cir.47.1.8","volume":"47","author":"RJ Frink","year":"1973","unstructured":"Frink RJ, James TN (1973) Normal blood supply to the human His bundle and proximal bundle branches. Circulation 47:8\u201318. https:\/\/doi.org\/10.1161\/01.cir.47.1.8","journal-title":"Circulation"},{"key":"1847_CR21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jacc.2019.05.053","volume":"74","author":"H Cui","year":"2019","unstructured":"Cui H, Schaff HV, Nishimura RA et al (2019) Conduction abnormalities and long-term mortality following septal myectomy in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 74:645\u2013655. https:\/\/doi.org\/10.1016\/j.jacc.2019.05.053","journal-title":"J Am Coll Cardiol"},{"key":"1847_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.amjcard.2003.09.034","volume":"93","author":"JX Qin","year":"2004","unstructured":"Qin JX, Shiota T, Lever HM et al (2004) Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions. Am J Cardiol 93:171\u2013175. https:\/\/doi.org\/10.1016\/j.amjcard.2003.09.034","journal-title":"Am J Cardiol"},{"key":"1847_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/clc.4960160410","volume":"16","author":"BF Waller","year":"1993","unstructured":"Waller BF, Gering LE, Branyas NA, Slack JD (1993) Anatomy, histology, and pathology of the cardiac conduction system: part II. Clin Cardiol 16:347\u2013352. https:\/\/doi.org\/10.1002\/clc.4960160410","journal-title":"Clin Cardiol"},{"key":"1847_CR24","unstructured":"Gietzen FH, Leuner CJ, Obergassel L, et al (2001) Symptomatic and hemodynamic effects of right bundle branch block induced by transcoronary ablation of septal hypertrophy (tash) for hypertrophic obstructive cardiomyopathy. Circulation, Abstracts"},{"key":"1847_CR25","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.amjcard.2006.08.067","volume":"99","author":"GP McCann","year":"2007","unstructured":"McCann GP, Van Dockum WG, Beek AM et al (2007) Extent of myocardial infarction and reverse remodeling assessed by cardiac magnetic resonance in patients with and without right bundle branch block following alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol 99:563\u2013567. https:\/\/doi.org\/10.1016\/j.amjcard.2006.08.067","journal-title":"Am J Cardiol"},{"key":"1847_CR26","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1136\/hrt.2008.158915","volume":"96","author":"E Galve","year":"2010","unstructured":"Galve E, Sambola A, Salda\u00f1a G et al (2010) Late benefits of dual-chamber pacing in obstructive hypertrophic cardiomyopathy: a 10\u00a0year follow-up study. Heart 96:352\u2013356. https:\/\/doi.org\/10.1136\/hrt.2008.158915","journal-title":"Heart"},{"key":"1847_CR27","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/oxfordjournals.eurheartj.a015435","volume":"18","author":"L Kappenberger","year":"1997","unstructured":"Kappenberger L, Linde C, Daubert C et al (1997) Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group Eur Heart J 18:1249\u20131256. https:\/\/doi.org\/10.1093\/oxfordjournals.eurheartj.a015435","journal-title":"PIC Study Group Eur Heart J"},{"key":"1847_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.acvd.2013.04.003","volume":"106","author":"A Lucon","year":"2013","unstructured":"Lucon A, Palud L, Pavin D et al (2013) Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy. Arch Cardiovasc Dis 106:373\u2013381. https:\/\/doi.org\/10.1016\/j.acvd.2013.04.003","journal-title":"Arch Cardiovasc Dis"},{"key":"1847_CR29","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.amjcard.2004.12.045","volume":"95","author":"A Megevand","year":"2005","unstructured":"Megevand A, Ingles J, Richmond DR, Semsarian C (2005) Long-term follow-up of patients with obstructive hypertrophic cardiomyopathy treated with dual-chamber pacing. Am J Cardiol 95:991\u2013993. https:\/\/doi.org\/10.1016\/j.amjcard.2004.12.045","journal-title":"Am J Cardiol"},{"key":"1847_CR30","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1161\/01.cir.99.22.2927","volume":"99","author":"BJ Maron","year":"1999","unstructured":"Maron BJ, Nishimura RA, McKenna WJ et al (1999) Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation 99:2927\u20132933. https:\/\/doi.org\/10.1161\/01.cir.99.22.2927","journal-title":"Circulation"},{"key":"1847_CR31","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/s0735-1097(96)00473-1","volume":"29","author":"RA Nishimura","year":"1997","unstructured":"Nishimura RA, Trusty JM, Hayes DL et al (1997) Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol 29:435\u2013441. https:\/\/doi.org\/10.1016\/s0735-1097(96)00473-1","journal-title":"J Am Coll Cardiol"},{"key":"1847_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/hrt.75.1.44","volume":"75","author":"AK Slade","year":"1996","unstructured":"Slade AK, Sadoul N, Shapiro L et al (1996) DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience. Heart 75:44\u201349. https:\/\/doi.org\/10.1136\/hrt.75.1.44","journal-title":"Heart"},{"key":"1847_CR33","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1253\/circj.69.536","volume":"69","author":"T Honda","year":"2005","unstructured":"Honda T, Shono H, Koyama J et al (2005) Impact of right atrial-left ventricular dual-chamber permanent pacing in patients with severely symptomatic hypertrophic obstructive cardiomyopathy. Circ J 69:536\u2013542. https:\/\/doi.org\/10.1253\/circj.69.536","journal-title":"Circ J"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-021-01847-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-021-01847-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-021-01847-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T11:30:36Z","timestamp":1643974236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-021-01847-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1847"],"URL":"https:\/\/doi.org\/10.1007\/s00392-021-01847-6","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,26]]},"assertion":[{"value":"4 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The research project was approved by the ethics committee of the Westf\u00e4lische Wilhelms-University M\u00fcnster, Germany (file number 2020-780-f-S).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Referring to the national ethical guidelines of Germany (\u00a76 Gesundheitsdatenschutzgesetz NRW) the authors waived consent to participate due to retrospective study design and only intra-departmental data collection in our analysis. This was approved by the ethics committee of the Westf\u00e4lische Wilhelms-University M\u00fcnster, Germany (file number 2020-780-f-S).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Referring to the national ethical guidelines of Germany (\u00a76 Gesundheitsdatenschutzgesetz NRW) the authors waived consent to publication due to retrospective study design and only intra-departmental data collection in our analysis. This was approved by the ethics committee of the Westf\u00e4lische Wilhelms-University M\u00fcnster, Germany (file number 2020-780-f-S).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}